< Back to Results
Primary Contact Name
Martin Kramer
Primary Contact Email Address
Martin.Kramer@Moffitt.org
Primary Contact Phone Number
813-745-2069
Program Name
Moffitt Blood and Marrow Transplant & Cellular Immunotherapy Fellowship
Address
12902 USF Magnolia Dr
CSB-GME
Tampa, FL, 33612
Website
https://www.moffitt.org/education/medical-education/our-training-programs/graduate-medical-education-residency-and-fellowship/blood-and-marrow-transplant-and-cellular-immunotherapy/
Program Director/Fellowship Director
Farhad Khimani
Program Director/Fellowship Director Email
Farhad.Khimani@Moffitt.org
Is the primary focus of your program on Blood and Marrow Transplantation (BMT) or Cellular Therapies?
BTH
How long is the Fellowship program at your institution?
One Year
How long is the BMT Fellowship program at your institution?
Not Provided
Option to extend training or research if funding is available?
No
Is the primary focus of your program on adult or pediatric populations?
Adult
How long before the Fellowship start date should applicants apply?
7-12 Months
When does your Fellowship application period begin?
July
When does your Fellowship application period end?
July
Interview Format
Flexible
How many training spaces?
Three
If you selected other, how many training spaces are there?
Not Provided
When does your program typically start?
July
If flexible, please describe
Not Provided
If you selected yes, please specify the type of visa
H1B
What are the requirements for fellows applying to your program?
Completion of residency training (Board Certified) or equivalent abroad, Completion of Hematology and/or Oncology Fellowship or equivalent (Board Eligible), ECFMG certification if IMG applicant, Eligibility to obtain a State Medical License
If you selected other, please explain
Not Provided
Are there any unique training opportunities in your fellowship program? (For example: rotation with CTRM, H&I Lab, exposure to CAR T Therapy, etc.)
Our program has 18 clinical and research faculty members who provide outstanding learning opportunities for fellows in both hematopoietic cell transplantation (HCT) and immune effector cell therapy (ICE-T) including CAR-T cell therapies. We currently offer six FDA-approved CD19 and BCMA CAR-T cell therapies for myeloma, lymphoma and Acute Lymphoblastic Leukemia and more than 25 research protocols utilizing cellular immunotherapies including CARs, TILs, TCRs, and DC vaccines. In addition to our numerous ICE-T Trials, our robust BMT Research program currently has more than 20 open clinical trials. We now perform more than 580 hematopoietic stem cell transplants and Immune Effector Cell infusions annually. Our Fellows have numerous opportunities to participate in research in immunotherapy, transplantation and GVHD prevention and therapy. We tailor the Fellowship experience for each of our fellows so that they may get both a robust HCT and ICE-T experience and gain expertise in their particular areas of interest.
Continuity Clinic with trainee as primary physician with supervision?
Yes
Approximate volume of cases at your center for the following
Autologous Transplant
200+
Allogeneic Transplant
200+
Approximate Structure (In weeks)
Inpatient
16
Other (specify)
PTO-25 days
Sample Schedule Upload
Not Provided
Educational Stipend/Conference funding available:
Yes - Specify
Specify the Educational Stipend/Conference funding available
up to $3500 per fellow. Plus 50 hours of faculty biostat support for each research project
If you were interested in the standard time frame, what part of the process would you be interested in standardizing?
Application Open, Application deadline, Interview Period, Selection Period
< Back to Results